Search Results - "Rubio, Itziar"

Refine Results
  1. 1

    Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells by Buqué, Aitziber, Muhialdin, Jangi Sh, Muñoz, Alberto, Calvo, Begoña, Carrera, Sergio, Aresti, Unai, Sancho, Aintzane, Rubio, Itziar, López-Vivanco, Guillermo

    Published in Molecular cancer (26-04-2012)
    “…Metastatic melanoma is a lethal skin cancer and its incidence is rising every year. It represents a challenge for oncologist, as the current treatment options…”
    Get full text
    Journal Article
  2. 2

    Thymidylate synthase expression determines pemetrexed targets and resistance development in tumour cells by Buqué, Aitziber, Aresti, Unai, Calvo, Begoña, Sh Muhialdin, Jangi, Muñoz, Alberto, Carrera, Sergio, Azkona, Eider, Rubio, Itziar, López-Vivanco, Guillermo

    Published in PloS one (13-05-2013)
    “…Although treatment options for cancer patients are increasing every year, the drug resistance problem remains very present. It is very difficult to find a drug…”
    Get full text
    Journal Article
  3. 3

    Concurrent chemoradiation and adjuvant chemotherapy in newly diagnosed glioblastoma multiforme: A retrospective analysis of single center by Iruarrizaga, Eluska, Iza, Estibaliz, Mañe, Joan Manel, Rubio, Itziar, Novo, Eneko, Lombardero, Lara, De Miguel, María José, Muñoz, Alberto

    Published in Journal of clinical oncology (01-06-2023)
    “…e14053 Background: The standard of care of glioblastoma multiforme (GBM) first line therapy is maximum safe debulking and posterior treatment based in…”
    Get full text
    Journal Article
  4. 4

    Glioblastoma in elderly patients: A retrospective analysis of survival and response based on molecular and clinical characteristics—Experience in our centre by Iza, Estibaliz, Mañe, Joan Manel, Iruarrizaga, Eluska, Rubio, Itziar, Fernandez, Ricardo, Jiménez, Pablo, Mohamed Lamin, Failah, Toquero, Mikel, Muñoz, Alberto

    Published in Journal of clinical oncology (01-06-2023)
    “…e14054 Background: Glioblastoma (GBM) is the most lethal and the most common malignant central nervous system tumor in adults. The standard treatment includes…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Bevacizumab (BV) plus irinotecan (I) in recurrent glioblastoma multiforme (GBM): A single center experience by Iruarrizaga, Eluska, Azkona, Eider, Aresti, Unai, Rubio, Itziar, Arruti, Mikel, Carrera, Sergio, Fuente, Natalia, Marrodan, Ines, Lopez Escola, Cristina, Condori, Elizabeth, Mane, Joan Manel, Lopez-Vivanco, Guillermo

    Published in Journal of clinical oncology (20-05-2013)
    “…Abstract only e13000 Background: Glioblastoma multiforme constitutes the most common and malignant form of primary brain tumor. Median survival for recurrent…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Adjuvant chemotherapy with cisplatin and gemcitabine in resected non-small cell lung cancer: A single institutional experience by Carrera, Sergio, Rubio, Itziar, Sancho, Aintzane, Marrodan, Ines, Muñoz, Alberto, Iza, Estibaliz, Iruarrizaga, Eluska, Buque, Aitziber, Calvo, Begoña, Aresti, Unai, Lopez-Vivanco, Guillermo

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only e17522 Background: Adjuvant chemotherapy in operable non small cell lung cancer (NSCLC) has been shown to improve overall survival in many…”
    Get full text
    Journal Article
  14. 14

    Bevacizumab plus chemotherapy in the treatment of metastatic breast cancer: Hospital of Cruces experience by Ferreiro, Josefa, Ruiz de Lobera, Abigail, Sancho, Aintzane, Carrera, Sergio, Marrodan, Ines, Rubio, Itziar, Iruarrizaga, Eluska, Azkona, Eider, Munoz Llarena, Alberto, Lopez-Vivanco, Guillermo

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only e11525 Background: Antiangiogenic therapies such as bevacizumab (BV), have proven to be effective in improving outcomes in metastatic disease…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Fixed-Dose-Rate Gemcitabine Infusion in Patients with Advanced Pancreatic or Biliary Tree Adenocarcinoma by Mané, Joan M, Sancho, Aintzane, Muñoz, Alberto, Rubio, Itziar, Fernández, Ricardo, Carrera, Sergio, Fuente, Natalia, Ballesteros, David, Casas, Raquel, Marrodán, Inés, Mielgo, Xabier, López-Vivanco, Guillermo

    Published in Tumori (01-05-2010)
    “…Aims and background Gemcitabine is an effective agent in pancreatic adenocarcinoma. Fixed-dose-rate gemcitabine has an interesting biological and clinical…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer by López-Vivanco, Guillermo, Viteri, Ainhoa, Barceló, Ramón, Muñoz, Alberto, Rubio, Itziar, Mañé, Joan Manel, Fuente, Natalia

    Published in American journal of clinical oncology (01-10-2005)
    “…In an attempt to increase the dose intensity of cisplatin and gemcitabine given to patients with stage IIIB or IV nonsmall cell lung cancer without increasing…”
    Get full text
    Journal Article
  20. 20